The primary components that define this drug include:
Core Mechanism of Action
Azatend-O mimics the natural nucleoside building blocks that cells use to synthesize genetic material.
- Tricking Cancer Cells: Rapidly dividing cancer cells mistakenly absorb the drug into their DNA and RNA chains.
- Gene Regulation: Once inside, it binds to and blocks specialized enzymes called DNA methyltransferases. This triggers "hypomethylation," which reactivates the body's natural tumor-suppressor genes to slow down or halt tumor growth.
- Cell Maturation: It halts the chaotic overproduction of immature cells, clearing the way for the bone marrow to produce normal, healthy blood cells again.
Primary Clinical Uses
It is specifically prescribed for adult patients who suffer from serious blood and bone marrow disorders and are ineligible for a hematopoietic stem cell transplant:
- Acute Myeloid Leukemia (AML): Used heavily as a continuous maintenance therapy to prolong survival and prevent the cancer from returning after initial chemotherapy has achieved remission.
- Myelodysplastic Syndromes (MDS): For high-risk cases where the bone marrow fails to produce enough functional mature blood cells.
- Chronic Myelomonocytic Leukemia (CMML): A rare overlap blood cancer marked by elevated monocyte counts.